Retrospective cohort study examines long-term impacts of SOF/VEL on decompensated cirrhosis, highlighting prognosis improvements.
SOF/VEL therapy achieved high SVR rates and demonstrated that post-treatment improvement in the ALBI score is strongly associated with a favorable long-term prognosis in patients with decompensated cirrhosis.
No takes yet. Share an insight, caveat, or question.
Kakizaki et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: